Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Rating) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 118,100 shares, a decline of 23.8% from the October 31st total of 154,900 shares. Approximately 1.2% of the company's stock are short sold. Based on an average trading volume of 78,300 shares, the days-to-cover ratio is presently 1.5 days.

Bluejay Diagnostics Trading Down 1.5 %

BJDX traded down $0.01 during trading on Friday, hitting $0.67. The company had a trading volume of 87,667 shares, compared to its average volume of 58,824. Bluejay Diagnostics has a one year low of $0.61 and a one year high of $3.59. The firm's 50-day moving average price is $0.78 and its 200 day moving average price is $0.98.

Institutional Investors Weigh In On Bluejay Diagnostics

Institutional investors have recently added to or reduced their stakes in the stock. Millennium Management LLC acquired a new stake in Bluejay Diagnostics in the 2nd quarter valued at $27,000. Virtu Financial LLC acquired a new stake in Bluejay Diagnostics in the 2nd quarter valued at $45,000. Finally, Renaissance Technologies LLC acquired a new stake in Bluejay Diagnostics in the 2nd quarter valued at $54,000. 1.21% of the stock is owned by institutional investors.

Bluejay Diagnostics Company Profile

Bluejay Diagnostics, Inc, a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components.

Further Reading

• Get a free copy of the StockNews.com research report on Bluejay Diagnostics (BJDX)
• Institutions Are Buying Ambarella, Should You?
• Can ZIM Defy Broad Downturn In The Container Shipping Industry?
• Ford Revving Up Production Of EV Power Units At U.K. Plant
• Are the Short Sellers Still Right About Mullen Automotive stock?
• La-Z-Boy Reclines To More Comfortable Levels

Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.